Location History:
- Chuo-ku, JP (2014)
- Tokyo, JP (2016)
Company Filing History:
2 out of 417 
1 out of 27 Years Active: 2014-2016
Title: Minoru Kameda: Innovator in Cancer Therapeutics
Introduction
Minoru Kameda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds for cancer treatment. With a focus on innovative solutions, Kameda has been awarded 2 patents for his groundbreaking work.
Latest Patents
Kameda's latest patents include a nitrogen-containing aromatic heterocyclic compound, which serves as a prophylactic and therapeutic agent for bladder cancer. This compound has shown inhibitory action on FGFR1, FGFR2, and FGFR3, especially targeting mutant FGFR3. It holds promise for treating various cancers, including lung cancer and hormone therapy-resistant breast cancer. Another notable patent is for a fused ring pyridine compound, which acts as an agonist on cannabinoid receptor type 2. This compound is designed to prevent and treat diseases related to this receptor, such as inflammatory diseases and pain.
Career Highlights
Throughout his career, Kameda has worked with notable companies, including Astellas Pharma GmbH and Kotobuki Pharmaceutical Co Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Kameda has collaborated with talented individuals in the field, including Ikumi Kuriwaki and Kazuhiko Iikubo. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Minoru Kameda's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to cancer therapeutics through his patents highlight the importance of research and collaboration in developing effective treatments.